We are live on ! Find out more
Alyeska Investment Group

Alyeska Investment Group Portfolio holdings

AUM $35.4B
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+33.54%
3 Year Est. Return
+101.08%
5 Year Est. Return
+102.29%
10 Year Est. Return
+544.32%
AUM
$10.6B
AUM Growth
-$234M
Cap. Flow
-$434M
Cap. Flow %
-4.08%
Top 10 Hldgs %
11.4%
Holding
561
New
183
Increased
121
Reduced
99
Closed
141

Sector Composition

Rank Sector Weight
1 Healthcare 17.9%
2 Technology 14.54%
3 Industrials 10.72%
4 Consumer Discretionary 10.71%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BHC icon
51
Bausch Health
BHC
$2.35B
$57.2M 0.54%
2,839,364
+639,364
+29% +$18.1M
HON icon
52
Honeywell
HON
$78.6B
$56.8M 0.53%
543,765
-327,609
-38% -$33.7M
LMT icon
53
Lockheed Martin
LMT
$133B
$56.3M 0.53%
+226,847
New +$53.5M
TRGP icon
54
Targa Resources
TRGP
$55.8B
$56.2M 0.53%
1,332,819
+525,488
+65% +$20.6M
NOW icon
55
ServiceNow
NOW
$121B
$55.8M 0.52%
+4,202,790
New +$58.4M
BHI
56
DELISTED
Baker Hughes
BHI
$55.3M 0.52%
+1,225,511
New +$55.5M
MGP
57
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$54.8M 0.51%
+2,054,602
New +$48.8M
ZBH icon
58
Zimmer Biomet
ZBH
$19B
$53.6M 0.5%
+458,566
New +$51.9M
BKU icon
59
Bankunited
BKU
$3.43B
$52.8M 0.5%
+1,718,219
New +$57.2M
ORCL icon
60
Oracle
ORCL
$416B
$52.8M 0.5%
+1,289,186
New +$51.5M
COF icon
61
Capital One
COF
$136B
$52.4M 0.49%
824,667
-324,501
-28% -$22.6M
CSC
62
DELISTED
Computer Sciences
CSC
$52.3M 0.49%
1,054,297
+328,357
+45% +$13.3M
TJX icon
63
TJX Companies
TJX
$177B
$52.1M 0.49%
1,348,764
+1,048,764
+350% +$40M
GRA
64
DELISTED
W.R. Grace & Co.
GRA
$51.8M 0.49%
706,880
+101,595
+17% +$7.77M
ALB icon
65
Albemarle
ALB
$14B
$51.6M 0.48%
650,000
+149,218
+30% +$11M
SYF icon
66
Synchrony
SYF
$25.8B
$51.3M 0.48%
2,028,548
-1,431,612
-41% -$41.7M
VMW
67
DELISTED
VMware, Inc
VMW
$51.3M 0.48%
895,792
-1,314,194
-59% -$75.8M
QLYS icon
68
Qualys
QLYS
$6.34B
$51.1M 0.48%
1,715,049
+63,000
+4% +$1.77M
MDLZ icon
69
Mondelez International
MDLZ
$79.9B
$51.1M 0.48%
1,121,836
-174,314
-13% -$7.6M
WAL icon
70
Western Alliance Bancorporation
WAL
$9.05B
$50.6M 0.47%
1,548,375
-344,250
-18% -$12.1M
VSTO
71
DELISTED
Vista Outdoor Inc.
VSTO
$50M 0.47%
1,047,124
-604,025
-37% -$29.2M
XRX icon
72
Xerox
XRX
$412M
$50M 0.47%
+1,998,226
New +$52.6M
JAZZ icon
73
Jazz Pharmaceuticals
JAZZ
$17B
$49.8M 0.47%
352,399
+103,946
+42% +$15.3M
COP icon
74
ConocoPhillips
COP
$140B
$49.5M 0.47%
+1,135,361
New +$50.1M
TYC
75
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$49.2M 0.46%
1,102,850
-940,127
-46% -$39.4M

Similar funds

Alyeska Investment Group's Q2 2016 Portfolio in Review

As of Q2 2016, Alyeska Investment Group held 561 positions worth $10.6B, down 2.2% from $10.9B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Alyeska Investment Group withdrew a net $434M in Q2 2016, closing 141 positions and reducing 99 holdings. Its most notable exit was Cisco, an estimated $151M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 15% a quarter earlier, followed by Technology and Industrials.

Against the trend, Alyeska Investment Group opened a new position in Baxter International worth $111M.

  • Alyeska Investment Group's largest Q2 2016 buy was Baxter International: 2,450,018 shares worth $111M.
  • Alyeska Investment Group added most to Whole Foods Market Inc in Q2 2016, an estimated $119M increase.
  • Alyeska Investment Group's biggest Q2 2016 reduction was Devon Energy, cutting an estimated $176M.
  • Alyeska Investment Group fully exited Cisco in Q2 2016, selling an estimated $151M.
  • Alyeska Investment Group's ten largest holdings make up 11% of its $10.6B portfolio in Q2 2016.
  • Alyeska Investment Group opened 183 new positions and closed 141 in Q2 2016.
  • Alyeska Investment Group's portfolio value fell 2.2% quarter-over-quarter to $10.6B.

Based on Alyeska Investment Group's 13F filing for Q2 2016, filed 15 Aug 2016.